ONYX PHARMACEUTICALS INC 4
4 · ONYX PHARMACEUTICALS INC · Filed Jul 29, 2013
Insider Transaction Report
Form 4
GRILLO LOPEZ ANTONIO J
Director
Transactions
- Exercise/Conversion
Common Stock
2013-07-26$76.79/sh+2,000$153,580→ 5,600 total - Sale
Common Stock
2013-07-26$130.50/sh−2,000$261,000→ 3,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-07-26−2,000→ 0 totalExercise: $76.79From: 2013-07-25Exp: 2022-07-24→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]Shares sold pursuant to 10b5-1 plan.